What is Edwards Lifesciences's treasury stock?

Edwards Lifesciences (EW) reported treasury stock of $7.51B in Q1 2026.

How has Edwards Lifesciences's treasury stock changed year-over-year?

Edwards Lifesciences's treasury stock increased by 16.5% year-over-year, from $6.45B to $7.51B.

What is the long-term trend for Edwards Lifesciences's treasury stock?

Over 4 years (2021 to 2025), Edwards Lifesciences's treasury stock has grown at a 30.9% compound annual growth rate (CAGR), from $2.42B to $7.09B.

What does treasury stock mean?

Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Edwards Lifesciences EW Treasury Stock

Treasury Stock at other companies

AbbottABT

$17.97B+8.2%

ArtivionAORT

$14.65M0.0%

ICU MedicalICUI

$25.18M+41,872%

LeMaitre VascularLMAT

$17.9M+10.4%

TFX

TeleflexTFX

$649.53M+85.4%

ITG

Integer HoldingsITGR

$114.23M+325%

Other financials

Income statement

See full

Revenue$1.7B+13.6%

Gross profit$1.3B+13.5%

Operating income$513.2M+24.8%

Net income$241.9M-27.4%

EPS (diluted)$0.42-25.0%

Balance sheet

See full

Cash & equivalents$2.4B-22.3%

Total debt$702.9M+0.5%

Total equity$10.3B+2.0%

Total assets$13.3B+2.3%

Cash flow

See full

Operating cash flow$43.8M-84.4%

CapEx$64.9M+15.9%

Free cash flow-$21.1M-109%

Valuation

See full

Market cap$47.58B+3.3%

Enterprise value$45.83B+11.0%

P/E47.4×+36.2×

P/S7.3×-0.8×

Profitability

See full

Gross margin77.8%-1.0pp

Operating margin22.3%-3.6pp

Net margin15.4%-57.5pp

FCF margin17.3%—

Returns & leverage

See full

Return on equity10.7%-37.8pp

Debt / equity0.1×0.0×

Current ratio4.4×0.0×

Where this comes from

Reported directly by Edwards Lifesciences in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edwards Lifesciences's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Edwards Lifesciences's treasury stock?: Edwards Lifesciences (EW) reported treasury stock of $7.51B in Q1 2026.
How has Edwards Lifesciences's treasury stock changed year-over-year?: Edwards Lifesciences's treasury stock increased by 16.5% year-over-year, from $6.45B to $7.51B.
What is the long-term trend for Edwards Lifesciences's treasury stock?: Over 4 years (2021 to 2025), Edwards Lifesciences's treasury stock has grown at a 30.9% compound annual growth rate (CAGR), from $2.42B to $7.09B.
What does treasury stock mean?: Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.